Adverse events occurring with an incidence of at least 5 in either treatment group during treatment, or within 14 days of the end of treatment Body system and adverse event by COSTART preferred term Anastrozole 1 mg N 3092 Gyraxen 20 mg N 3094 Body as a whole Asthenia 575 19 544 18 Pain 533 17 485 16 Back pain 321 10 309 10 Headache 314 10 249 8 Abdominal pain 271 9 276 9 Infection 285 9 276 9 Accidental injury 311 10 303 10 Flu syndrome 175 6 195 6 Chest pain 200 7 150 5 Neoplasm 162 5 144 5 Cyst 138 5 162 5 Cardiovascular Vasodilatation 1104 36 1264 41 Hypertension 402 13 349 11 Digestive Nausea 343 11 335 11 Constipation 249 8 252 8 Diarrhea 265 9 216 7 Dyspepsia 206 7 169 6 Gastrointestinal disorder 210 7 158 5 Hemic and lymphatic Lymphoedema 304 10 341 11 Anemia 113 4 159 5 Metabolic and nutritional Peripheral edema 311 10 343 11 Weight gain 285 9 274 9 Hypercholesterolemia 278 9 108 3 <a href=http://lasix.buzz>furosemida tabletas enlina</a> 10, 11 No such risk was seen with less potent inhibitors, specifically citalopram
